Search This Blog

Showing posts with label Young Investigators. Show all posts
Showing posts with label Young Investigators. Show all posts

Thursday, 9 July 2015

Madrid EACPT Masterclass by EACPT official journal editor Richard Shader on how to publish in scientific journals

The 12th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics (http://eacpt.eu) was held in Madrid from 27th to 30th June 2015. Over 500 abstracts were accepted from 66 countries and from all 5 continents for presentation as e-posters and oral presentations. the 54 oral presentations were eligible for an award for the best talk. 

At a well-attended EACPT Congress session, EACPT official journal editor Richard Shader gave a Masterclass to over 80 delegates on how publish a scientific paper.

Listen to Dr Shader discussing Clinical Therapeutics with Donald Singer from the EACPT:



Dr Shader's key messages on scientific writing included

- write clearly
- explain why you undertook the work
- describe how you advanced knowledge in the field.
- note further work that would take the field forward

- decide title and write abstract last - avoid excessive use of adverbs  
 - use short sentences
- consider use of translation support if English is not your first language: this should be translation of your own text, NOT ghost writing

More helpful advice for authors

The European Association of Clinical Pharmacology and Therapeutics has Clinical Therapeutics as its Official Journal, in partnership with the major international publisher Elsevier. 

The journal features highlights of EACPT scientific and other activities and provides information on future EACPT congresses, summer schools and other events. The journal  also publishes peer-reviewed original papers and reviews arising from EACPT conferences. 

Wednesday, 8 July 2015

2015 EACPT Scientific Award and Joint EACPT-EPHAR Translational Pharmacology Awards


The 12th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics (http://eacpt.eu) was held in Madrid from 27th to 30th June 2015. Over 500 abstracts were accepted from 66 countries and from all 5 continents for presentation as e-posters and oral presentations. The 54 oral presentations were eligible for awards for best talks. The 2015 EACPT Scientific Award and Joint EACPT-EPHAR Translational Pharmacology Awards were presented at the end of June at the EACPT Congress in Madrid.
Listen to these 2015 EACPT Award winners discussing the research which led to their awards.


EACPT Scientific Award was conferred on UK Scientist Professor Nicholas Bateman for work on treating paracetamol overdose. The EACPT Scientific Award, which includes a prize of 2000€, was presented to Professor Bateman at the 12th EACPT Congress in Madrid in June 2015. 
The inaugural EACPT-EPHAR Young Investigator Awards in Translational Pharmacology have been conferred on PhD student Christoph Schneider from Bern in Switzerland and Dr Daniel Antoine from Liverpool in the UK.
Donald Singer (EACPT EC), Nicholas Bateman and Tabassome Simon (EACPT Chair)
Professor Bateman's research, which was published in the international medical journal The Lancet, involved a clinical trial comparing a new regimen to treat paracetamol poisoning with the current one (which has been used for over 40 years). It is the first large-scale, properly powered and randomised controlled clinical trial conducted in paracetamol poisoning, a challenging environment for trial work. 

The Federation of European Pharmacology Societies (EPHAR) and the European
Thomas Griesbacher (EPHAR President), Christoph Schneider, Dr Daniel Antoine, Tabassome Simon (EACPT Chair)
Association for Clinical Pharmacology and Therapeutics (EACPT) developed the above Young Investigator joint initiative to recognise projects of excellence in translational research in pharmacology. 2 awards of EUR 1,000 each were given EACPT Congress in Madrid to Christoph Schneider and Dr Daniel Antoine for their recent outstanding research papers. 

Requirements for the EACPT-EPHAR Young Investigator Awards in Translational Pharmacology are that applicants must be not more than 35 years of age on the deadline date, have as first author published an outstanding paper in the 2 years prior to the Awards, have conducted the submitted study in an institution of a country member of EACPT and/or EPHAR; and be a member of one of the member societies of EPHAR or EACPT, or be an individual associate member of EACPT.